Navigation Links
GEN reports on growth of biobanking operations
Date:9/19/2012

New Rochelle, NY, September 19, 2012 Many biotech observers maintain that the future of healthcare will largely be based on the field of personalized medicine, reports Genetic Engineering & Biotechnology News (GEN) (http://genengnews.com). Although drug discovery efforts require access to increasingly larger arrays of biosamples, demand is exceeding supply, fueling the growth of the biobanking market, according to a recent issue of GEN (http://genengnews.com/gen-articles/biobanking-confronts-growing-pains/4481).

"Personalized medicine is all about tailoring specific therapies for individual patients," said John Sterling, Editor-in-Chief of GEN. "Scientists are faced with a growing need for biospecimens such as blood, saliva, plasma, and purified DNA to move personalized medicine research forward. Bio-repositories and biobanks will continue to play a critical role in this work."

Sources for human material range from those that provide postmortem material, such as the International Institute for the Advancement of Medicine (IIAM), to consortia that provide samples from living donors with specific diseases, such as the Lung Tissue Research Consortium. Depending on source, varying amounts of donor information are supplied with the human materials.

One key development is the emergence of virtual biobanking, where companies provide a single point of access to a range of biospecimens. Using networks of ethical sources, they find the tissues required to the specifications provided by the requester, and then deliver them to the requester. This streamlines the procurement of tissue and benefits all parties.


'/>"/>
Contact: John Sterling
jsterling@genengnews.com
914-740-2196
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert  

Page: 1

Related biology news :

1. GEN reports on recent progress in Alzheimers research
2. BGI reports the latest finding on NMNAT1 mutations linked to Leber congenital amaurosis
3. Aware, Inc. Reports Second Quarter 2012 Financial Results
4. GEN reports on growth of tissue engineering revenues
5. BGI reports the completed sequence of foxtail millet genome
6. Radiologists study necessity of additional imaging recommendations in PET/CT oncologic reports
7. Aware, Inc. Reports First Quarter 2012 Financial Results
8. RUB researchers clarify catalysis mechanism of cell growth protein Ras
9. Smart growth strategies curb car use, greenhouse gas emissions, SF State study suggests
10. Hulk protein, Grb10, controls muscle growth
11. Breast milk promotes a different gut flora growth than infant formulas
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
GEN reports on growth of biobanking operations
(Date:5/12/2016)... May 12, 2016 WearablesResearch.com , a ... the overview results from the Q1 wave of its ... wave was consumers, receptivity to a program where they ... a health insurance company. "We were surprised ... says Michael LaColla , CEO of Troubadour Research, ...
(Date:4/28/2016)... 2016 First quarter 2016:   ... with the first quarter of 2015 The gross margin ... (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... unchanged, SEK 7,000-8,500 M. The operating margin for 2016 ...
(Date:4/15/2016)...  A new partnership announced today will help ... in a fraction of the time it takes ... life insurance policies to consumers without requiring inconvenient ... Diagnostics, rapid testing (A1C, Cotinine and HIV) and ... weight, pulse, BMI, and activity data) available at ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is ... has received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval ... Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods ...
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... In a ... Hospital in Denmark detail how a patient who developed lymphedema after being treated for ... The results could change the paradigm for dealing with this debilitating, frequent side effect ...
Breaking Biology Technology: